| Identification | Back Directory | [Name]
9ALPHA,11ALPHA-METHYLENE-15S-HYDROXY-11A-DEOXY-11A-METHYLENE-THROMBA-5Z,13E-DIEN-1-OIC ACID | [CAS]
74034-56-3 | [Synonyms]
CTA2
Carbocyclic TxA2
CARBOCYCLIC THROMBOXANE A2
(+/-)CARBOCYCLIC THROMBOXANE
(Z)-7-[(2S)-3β-[(1E,3S)-3-Hydroxy-1-octenyl]bicyclo[3.1.1]heptan-2α-yl]-5-heptenoic acid
9ALPHA,11ALPHA-METHYLENE-15S-HYDROXY-11A-DEOXY-11A-METHYLENE-THROMBA-5Z,13E-DIEN-1-OIC ACID
5-Heptenoic acid, 7-[(2S,3R)-3-[(1E,3S)-3-hydroxy-1-octen-1-yl]bicyclo[3.1.1]hept-2-yl]-, (5Z)- | [Molecular Formula]
C22H36O3 | [MDL Number]
MFCD00065807 | [MOL File]
74034-56-3.mol | [Molecular Weight]
348.52 |
| Hazard Information | Back Directory | [Description]
Carbocyclic thromboxane A2 (CTA2) is a stable analog of TXA2. CTA2 is a potent coronary vasoconstrictor and is effective at concentrations as low as 1 nM in cat coronary arteries. Unlike other vascular TP receptor agonists, CTA2 is a potent inhibitor of prostanoid-induced platelet aggregation. It inhibits arachidonic acid-induced aggregation with an IC50 value of 4-5 μM. CTA2 also exhibits selective and dose-dependent inhibition of TXB2 synthesis in rabbit platelets at concentrations between 1 and 100 μM. | [Uses]
Carbocyclic Thromboxane A2 is a stable analog of TXA2 which inhibits thromboxane-mediated vasoconstriction platelet aggregation. Also, it converts the thromboxane synthase (TXAS) heme cofactor to its 5-coordinate. |
|
| Company Name: |
Energy Chemical
|
| Telephone: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
| Company Name: |
amyjet
|
| Telephone: |
4006800868;027-59626688 18771149750 |
| Website: |
http://www.amyjet.com/ |
|